CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway

Molecular and Cellular Biology

Volumn 31, Issue 7, 2011, Pages 1459-1469

  Sabbah, Michèle ^a   Prunier, Céline ^a   Ferrand, Nathalie ^a   Megalophonos, Virginie ^a   Lambein, Kathleen ^b   De Wever, Olivier ^b   Nazaret, Nicolas ^c   Lachuer, Joël ^c   Dumont, Sylvie ^d   Redeuilh, Gérard ^a  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Université Pierre et Marie Curie IFR65 ^*  (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CCN5 PROTEIN; GROWTH FACTOR; HISTONE DEACETYLASE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CELL STRAIN HEK293; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

CADHERINS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HISTONE DEACETYLASES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 79953780809     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01316-10     Document Type: Article

References (54)

1. Ammanamanchi, S., S. J. Kim, L. Z. Sun, and M. G. Brattain. 1998. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2′-deoxycytidine. J. Biol. Chem. 273:16527-16534.
2. Anonymous. 2001. Proposal for a unified CCN nomenclature. Mol. Pathol. 54:108.
3. Bae, H. W., et al. 1995. Characterization of the promoter region of the human transforming growth factor-beta type II receptor gene. J. Biol. Chem. 270:29460-29468.
4. Banerjee, S., et al. 2008. CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. Cancer Res. 68:7606-7612.
5. Banerjee, S., et al. 2003. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia 5:63-73.
6. Bates, R. C., and A. M. Mercurio. 2005. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther. 4:365-370.
7. Brigstock, D. R. 2003. The CCN family: a new stimulus package. J. Endocrinol. 178:169-175.
8. Brigstock, D. R. 1999. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr. Rev. 20:189-206.
9. Brigstock, D. R., et al. 2003. Proposal for a unified CCN nomenclature. Mol. Pathol. 56:127-128.
10. Chen, X., et al. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389:85-89.
11. Dennler, S., C. Prunier, N. Ferrand, J. M. Gauthier, and A. Atfi. 2000. c-Jun inhibits transforming growth factor beta-mediated transcription by repressing Smad3 transcriptional activity. J. Biol. Chem. 275:28858-28865.
12. De Wever, O., et al. 2010. Modeling and quantification of cancer cell invasion through collagen type I matrices. Int. J. Dev. Biol. 54:887-896.
13. De Wever, O., et al. 2008. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem. Cell Biol. 130:481-494.
14. Dhar, G., et al. 2007. Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Cancer Lett. 254:63-70.
15. Dhasarathy, A., M. Kajita, and P. A. Wade. 2007. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol. Endocrinol. 21:2907-2918.
16. Fèvre-Montange, M., et al. 2006. Microarray analysis reveals differential gene expression patterns in tumors of the pineal region. J. Neuropathol. Exp. Neurol. 65:675-684.
17. Fritah, A., G. Redeuilh, and M. Sabbah. 2006. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens. J. Endocrinol. 191:613-624.
18. Fritah, A., et al. 2008. Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol. Cell. Biol. 28:1114-1123.
19. Fritah, A., C. Saucier, J. Mester, G. Redeuilh, and M. Sabbah. 2005. p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Mol. Cell. Biol. 25:2419-2430.
20. Gray, M. R., J. A. Malmquist, M. Sullivan, M. Blea, and J. J. Castellot, Jr. 2007. CCN5 expression in mammals. II. Adult rodent tissues. J. Cell Commun. Signal. 1:145-158.
21. Huang, L., Y. Sowa, T. Sakai, and A. B. Pardee. 2000. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene 19:5712-5719.
22. Huang, W., et al. 2008. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Am. J. Pathol. 172:893-904.
23. Inadera, H., et al. 2000. WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem. Biophys. Res. Commun. 275:108-114.
24. James, D., A. J. Levine, D. Besser, and A. Hemmati-Brivanlou. 2005. TGF-beta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132:1273-1282.
25. Jepsen, K., and M. G. Rosenfeld. 2002. Biological roles and mechanistic actions of co-repressor complexes. J. Cell Sci. 115:689-698.
26. Johnson, H. M., P. S. Subramaniam, S. Olsnes, and D. A. Jans. 2004. Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. Bioessays 26:993-1004.
27. Jones, J. A., M. R. Gray, B. E. Oliveira, M. Koch, and J. J. Castellot, Jr. 2007. CCN5 expression in mammals. I. Embryonic and fetal tissues of mouse and human. J. Cell Commun. Signal. 1:127-143.
28. Kouzarides, T. 1999. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9:40-48.
29. Leask, A., and D. J. Abraham. 2006. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 119: 4803-4810.
30. Lemercier, C., et al. 2000. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275: 15594-15599.
31. Mason, H. R., A. C. Lake, J. E. Wubben, R. A. Nowak, and J. J. Castellot, Jr. 2004. The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol. Hum. Reprod. 10:181-187.
32. Matsuda, T., T. Yamamoto, A. Muraguchi, and F. Saatcioglu. 2001. Crosstalk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J. Biol. Chem. 276:42908-42914.
33. Ng, H. H., and A. Bird. 2000. Histone deacetylases: silencers for hire. Trends Biochem. Sci. 25:121-126.
34. Olsnes, S., O. Klingenberg, and A. Wiedlocha. 2003. Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus. Physiol. Rev. 83:163-182.
35. Pennica, D., et al. 1998. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. U. S. A. 95:14717-14722.
36. Pessah, M., et al. 2001. c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity. Proc. Natl. Acad. Sci. U. S. A. 98:6198-6203.
37. Planque, N. 2006. Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers. Cell Commun. Signal. 4:7.
38. Planque, N., C. Long Li, S. Saule, A. M. Bleau, and B. Perbal. 2006. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins. J. Cell. Biochem. 99:105-116.
39. Planque, N., and B. Perbal. 2003. A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int. 3:15.
40. Prunier, C., N. Ferrand, B. Frottier, M. Pessah, and A. Atfi. 2001. Mechanism for mutational inactivation of the tumor suppressor Smad2. Mol. Cell. Biol. 21:3302-3313.
41. Rachfal, A. W., and D. R. Brigstock. 2005. Structural and functional properties of CCN proteins. Vitam. Horm. 70:69-103.
42. Roberts, A. B., and L. M. Wakefield. 2003. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 100: 8621-8623.
43. Sabbah, M., et al. 2008. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist. Updat. 11:123-151.
44. Sexton, T., H. Schober, P. Fraser, and S. M. Gasser. 2007. Gene regulation through nuclear organization. Nat. Struct. Mol. Biol. 14:1049-1055.
45. Sun, L., et al. 1994. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem. 269:26449-26455.
46. Thiery, J. P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442-454.
47. Vleminckx, K., L. Vakaet, Jr., M. Mareel, W. Fiers, and F. van Roy. 1991. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119.
48. Wahab, N. A., H. Brinkman, and R. M. Mason. 2001. Uptake and intracellular transport of the connective tissue growth factor: a potential mode of action. Biochem. J. 359:89-97.
49. Wei, L. N., X. Hu, D. Chandra, E. Seto, and M. Farooqui. 2000. Receptorinteracting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem. 275:40782-40787.
50. Wiesman, K. C., et al. 2010. CCN5, a secreted protein, localizes to the nucleus. J. Cell Commun. Signal. 4:91-98.
51. Yang, J., and R. A. Weinberg. 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14:818-829.
52. Yang, S. H., E. Vickers, A. Brehm, T. Kouzarides, and A. D. Sharrocks. 2001. Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. Mol. Cell. Biol. 21:2802-2814.
53. Zavadil, J., and E. P. Bottinger. 2005. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24:5764-5774.
54. Zhao, S., K. Venkatasubbarao, S. Li, and J. W. Freeman. 2003. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta type II receptor expression in human pancreatic cancer cells. Cancer Res. 63:2624-2630.